1. Ali-Osman F., Brunner J. M., Kutluk T. M. and Hess K. 1997 Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin. Cancer Res. 3, 2253–2261.
2. Ateş N. A., Tamer L., Ateş, C., Ercan B., Elipek T., Öcal K. and Camdeviren H. 2005 Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem. Genet. 43, 149–163.
3. Autrup H. 2000 Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464, 65–76.
4. Baccarani M., Castagnetti F., Gugliotta G. and Rosti G. 2015 A review of the European LeukemiaNet recommendations for the management of CML. Ann. Hematol. 94, 141–147.
5. Ban N., Takahashi Y., Takayama T., Kura T., Sakamaki S. and Niitsu Y. 1996 Transfection of glutathione S-transferase (GST)- $$\pi $$ π antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res. 56, 3577–3582.